NVIDIA-Backed SandboxAQ accelerates drug discovery
SandboxAQ, a Google-born AI startup backed by NVIDIA, just released a huge dataset—5.2 million synthetic 3D molecules—to help speed up drug discovery.
Built using NVIDIA's tech and validated by real-world experiments, these molecules are designed to train AI models that can quickly predict how drugs interact with proteins.
AI can now help in drug discovery
With this dataset, scientists can use AI to scan potential drugs way faster than old-school manual methods.
SandboxAQ plans to sell advanced AI models based on this data, aiming for results as reliable as actual lab tests.
The company already has close to $1 billion in funding from investors who believe it could change early-stage drug research.
Dataset enhances the speed and scale of virtual screening
By combining smart computational tools and real experimental data, SandboxAQ's approach tackles one of the toughest parts of drug development: finding promising compounds fast.
Their dataset is designed to enhance the speed and scale of virtual screening, potentially giving them a strong edge in the race for better medicines.